Adaptive feedback-controlled infusion versus repetitive injections of vecuronium in patients during isoflurane anesthesia

Ebeling, B. J.; Müller, Wendt; Tonner, Peter H.; Olkkola, Klaus T.; Stoeckel, H.

doi:10.1016/0952-8180(91)90156-h

Cited by 6 publications

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There are a number of successful illustrations of the use of model based methods to individualise therapy [31,32,33,34,35,36,37,38]. One example relates to the individualisation of carboplatin treatment based on thrombocytopenia.…”

Section: Potential For Model-based Methodsmentioning

confidence: 99%

Beyond Genetics—Stratified and Personalised Medicines Using Multiple Parameters

Peck

Smith

2010

Pharmaceuticals

View full text Add to dashboard Cite

Prescribers have been practicing stratified medicine for many years. Patient characteristics, usually non-genetic, including age, comorbidities and concomitant medications are taken into account when deciding which drug to prescribe. In addition, the majority of drugs require dose adjustments across patient subgroups, usually determined by non-genetic differences between the subgroups. Whilst pharmacogenetics hold promise for enhancing treatment stratification and even treatment individualisation, non-genetic factors will continue to be very important. Both non-genetic and genetic factors must be considered to improve understanding and quantification of the variability in treatment outcomes and to guide stratification and targeting of patient subgroups to the right drug and also to the right range of doses within that subgroup. Development of stratified medicines must consider non-genetic as well as genetic factors and, where appropriate, include stratification through optimising the dose for each patient or subgroup as well as by choosing the drug most likely to deliver efficacy to that patient or group.

show abstract